X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE DIVIS LABORATORIES SUVEN LIFE/
DIVIS LABORATORIES
 
P/E (TTM) x 17.2 33.7 50.9% View Chart
P/BV x 3.5 6.0 58.7% View Chart
Dividend Yield % 0.6 0.8 78.5%  

Financials

 SUVEN LIFE   DIVIS LABORATORIES
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
DIVIS LABORATORIES
Mar-17
SUVEN LIFE/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2511,222 20.5%   
Low Rs155784 19.8%   
Sales per share (Unadj.) Rs49.1153.1 32.1%  
Earnings per share (Unadj.) Rs9.739.9 24.3%  
Cash flow per share (Unadj.) Rs11.444.6 25.5%  
Dividends per share (Unadj.) Rs1.5010.00 15.0%  
Dividend yield (eoy) %0.71.0 74.1%  
Book value per share (Unadj.) Rs60.3201.8 29.9%  
Shares outstanding (eoy) m127.28265.47 47.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.16.6 63.0%   
Avg P/E ratio x20.925.1 83.2%  
P/CF ratio (eoy) x17.822.5 79.2%  
Price / Book Value ratio x3.45.0 67.7%  
Dividend payout %15.425.0 61.7%   
Avg Mkt Cap Rs m25,825266,266 9.7%   
No. of employees `0001.19.7 11.0%   
Total wages/salary Rs m6134,687 13.1%   
Avg. sales/employee Rs Th5,832.64,175.0 139.7%   
Avg. wages/employee Rs Th571.5481.5 118.7%   
Avg. net profit/employee Rs Th1,153.81,089.3 105.9%   
INCOME DATA
Net Sales Rs m6,25340,643 15.4%  
Other income Rs m233749 31.1%   
Total revenues Rs m6,48541,392 15.7%   
Gross profit Rs m1,98214,460 13.7%  
Depreciation Rs m2131,233 17.3%   
Interest Rs m4623 204.9%   
Profit before tax Rs m1,95513,953 14.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7183,349 21.4%   
Profit after tax Rs m1,23710,604 11.7%  
Gross profit margin %31.735.6 89.1%  
Effective tax rate %36.724.0 153.1%   
Net profit margin %19.826.1 75.8%  
BALANCE SHEET DATA
Current assets Rs m5,62240,105 14.0%   
Current liabilities Rs m1,1686,595 17.7%   
Net working cap to sales %71.282.5 86.4%  
Current ratio x4.86.1 79.2%  
Inventory Days Days81119 68.7%  
Debtors Days Days3681 44.5%  
Net fixed assets Rs m3,32519,995 16.6%   
Share capital Rs m127531 24.0%   
"Free" reserves Rs m7,54753,043 14.2%   
Net worth Rs m7,67453,574 14.3%   
Long term debt Rs m140-   
Total assets Rs m9,13561,585 14.8%  
Interest coverage x43.2618.4 7.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.7 103.7%   
Return on assets %14.017.3 81.4%  
Return on equity %16.119.8 81.4%  
Return on capital %26.026.1 99.8%  
Exports to sales %00-   
Imports to sales %025.2 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA10,259 0.0%   
Fx inflow Rs m5,06635,384 14.3%   
Fx outflow Rs m2,00110,399 19.2%   
Net fx Rs m3,06524,985 12.3%   
CASH FLOW
From Operations Rs m69911,493 6.1%  
From Investments Rs m-6-11,372 0.1%  
From Financial Activity Rs m-577-93 619.8%  
Net Cashflow Rs m11628 409.5%  

Share Holding

Indian Promoters % 63.4 52.0 121.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.8 -  
FIIs % 0.0 19.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.2 212.2%  
Shareholders   37,287 31,796 117.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  DR. REDDYS LAB  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Nifty Crosses 11,500-Mark; L&T Surges 4% on Buyback News(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.2% while the Hang Seng is up 0.7%.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

DIVIS LABORATORIES Announces Quarterly Results (1QFY19); Net Profit Up 50.8% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 50.8% YoY). Sales on the other hand came in at Rs 10 bn (up 21.2% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 20, 2018 10:41 AM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS